Skip to main content
SpringerLink
Log in

Less Common Causes of Quadriparesis and Respiratory Failure

  • Chapter
Book cover Critical Care Neurology and Neurosurgery

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

After the more common illnesses that lead to weakness and respiratory failure have been excluded, establishing the definitive diagnosis leading to weakness and respiratory failure becomes more challenging. In this chapter, we present the less common conditions that lead to quadriparesis and respiratory failure. These diseases have distinct clinical presentations and mostly affect the peripheral nerves, the neuromuscular junction and muscles. Early recognition may lead to successful management. We present an overview of these diseases, their clinical presentation and management with emphasis on critical care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Centers for Disease Control. Progress toward the global elimination of neonatal tetanus, 1988–1993. MMWR 1994; 43: 885–894.

    Google Scholar 

  2. Centers for Disease Control. Tetanus Surveillance-United States, 1995–1997. MMWR 1998; 47: 1–13.

    Google Scholar 

  3. Bleck T, Brauner J. Tetanus. In: Scheld W, Whitely R, Durack D (eds). Infections of the Central Nervous System, 2nd ed. Philadelphia: Lippincott-Raven, 1997: 629–653.

    Google Scholar 

  4. Stoll BJ. Tetanus. Pediatr. Clin. North Am. 1979; 26: 415–431.

    PubMed  CAS  Google Scholar 

  5. Hsu SS, Groleau G. Tetanus in the emergency department: A current review. J. Emerg. Med. 2001; 20: 357–365.

    Article  PubMed  CAS  Google Scholar 

  6. Jagoda A, Riggio S, Burguieres T. Cephalic tetanus: A case report and review of the literature. Am. J. Emerg. Med. 1988; 6: 128–30.

    Article  PubMed  CAS  Google Scholar 

  7. Apte NM, Karnad DR. Short report: the spatula test: A simple bedside test to diagnose tetanus. Am. J. Trop. Med. Hyg. 1995; 53: 386–387.

    PubMed  CAS  Google Scholar 

  8. Trujillo MH, Castillo A, Espana J, Manzo A, Zerpa R. Impact of intensive care management on the prognosis of tetanus. Analysis of 641 cases. Chest 1987; 92: 63–65.

    Article  PubMed  CAS  Google Scholar 

  9. Wright DK, Lalloo UG, Nayiager S, Govender P. Autonomic nervous system dysfunction in severe tetanus: current perspectives. Crit. Care Med. 1989; 17: 371–375.

    Article  PubMed  CAS  Google Scholar 

  10. King WW, Cave DR. Use of esmolol to control autonomic instability of tetanus. Am. J. Med. 1991; 91: 425–428.

    Article  PubMed  CAS  Google Scholar 

  11. Domenighetti GM, Savary G, Stricker H. Hyperadrenergic syndrome in severe tetanus: Extreme rise in catecholamines responsive to labetalol. BMJ 1984; 288: 1483–1484.

    Article  PubMed  CAS  Google Scholar 

  12. Sutton DN, Tremlett MR, Woodcock TE, Nielsen MS. Management of autonomic dysfunction in severe tetanus: the use of magnesium sulphate and clonidine. Intensive Care Med. 1990; 16: 75–80.

    Article  PubMed  CAS  Google Scholar 

  13. Brown JL, Sinding H, Mathias CJ. Autonomic disturbance in severe tetanus: failure of parenteral clonidine to control blood pressure. J. Infect. 1994; 29: 67–71.

    Article  PubMed  CAS  Google Scholar 

  14. Moughabghab AV, Prevost G, Socolovsky C. Fentanyl therapy controls autonomic hyperactivity in tetanus. Br. J. Clin. Pract. 1996; 50: 477–478.

    PubMed  CAS  Google Scholar 

  15. Southorn PA, Blaise GA. Treatment of tetanus-induced autonomic nervous system dysfunction with continuous epidural blockade. Crit. Care Med. 1986; 14: 251–252.

    Article  PubMed  CAS  Google Scholar 

  16. Farquhar I, Hutchinson A, Curran J. Dantrolene in severe tetanus. Intensive Care Med. 1988; 14: 249–250.

    Article  PubMed  CAS  Google Scholar 

  17. Brock H, Moosbauer W, Gabriel C, Necek S, Bidal D. Treatment of severe tetanus by continuous intrathecal infusion of baclofen. J. Neurol. Neurosurg. Psychiatry 1995; 59: 193–194.

    Article  PubMed  CAS  Google Scholar 

  18. Fassoulaki A, Eforakopoulou M. Vecuronium in the management of tetanus. Is it the muscle relaxant of choice? Acta. Anaesthesiol. Belg. 1988; 39: 75–78.

    PubMed  CAS  Google Scholar 

  19. Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 1992; 76: 822–843.

    Article  PubMed  CAS  Google Scholar 

  20. John DA, Tobey RE, Homer LD, Rice CL. Onset of succinylcholine-induced hyperkalemia following denervation. Anesthesiology 1976; 45: 294–299.

    Article  PubMed  CAS  Google Scholar 

  21. Sanford JP. Tetanus—forgotten but not gone. N. Engl. J. Med. 1995; 332: 812–813.

    Article  PubMed  CAS  Google Scholar 

  22. Ahmadsyah I, Salim A. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. BMJ 1985; 291: 648–650.

    Article  PubMed  CAS  Google Scholar 

  23. Spenney JG, Lamb RN, Cobbs CG. Recurrent tetanus. South Med. J. 1971;64:859 passim.

    Google Scholar 

  24. Amato AA. Acid maltase deficiency and related myopathies. Neurol. Clin. 2000; 18: 151–165.

    Article  PubMed  CAS  Google Scholar 

  25. Barohn RJ, McVey AL, DiMauro S. Adult acid maltase deficiency. Muscle Nerve 1993; 16: 672–676.

    Article  PubMed  CAS  Google Scholar 

  26. Engel AG, Gomez MR, Seybold ME, Lambert EH. The spectrum and diagnosis of acid maltase deficiency. Neurology 1973; 23: 95–106.

    Article  PubMed  CAS  Google Scholar 

  27. Felice KJ, Alessi AG, Grunnet ML. Clinical variability in adult-onset acid maltase deficiency: Report of affected sibs and review of the literature. Medicine (Baltimore) 1995; 74: 131–135.

    Article  CAS  Google Scholar 

  28. Wokke JH, Ausems MG, van den Boogaard MJ, Ippel EF, van Diggelene O, Kroos MA, et al. Genotype-phenotype correlation in adult-onset acid maltase deficiency. Ann. Neurol. 1995; 38: 450–454.

    Article  PubMed  CAS  Google Scholar 

  29. Reuser AJ, Kroos MA, Hermans MM, Bijvoet AG, Verbeet MP, Van Diggelen OP, et al. Glycogenosis type II (acid maltase deficiency). Muscle Nerve 1995; 3: S61 - S69.

    Article  PubMed  CAS  Google Scholar 

  30. Engel A, Hirschorn R. Acid maltase deficiency. In: Engel A, Franzini-Armstrong C (eds). Myology. New York: McGraw Hill, 1994: 1533–1553.

    Google Scholar 

  31. Gambetti P, DiMauro S, Baker L. Nervous system in Pompe’s disease. Ultrastructure and biochemistry. J. Neuropathol. Exp. Neurol. 1971; 30: 412–430.

    Article  PubMed  CAS  Google Scholar 

  32. Raben N, Nichols RC, Boerkoel C, Plotz P. Genetic defects in patients with glycogenosis type II (acid maltase deficiency). Muscle Nerve 1995; 3: S70 - S74.

    Article  PubMed  CAS  Google Scholar 

  33. Bulkley BH, Hutchins GM. Pompe’s disease presenting as hypertrophic myocardiopathy with Wolff- Parkinson-White syndrome. Am. Heart J. 1978; 96: 246–252.

    Article  PubMed  CAS  Google Scholar 

  34. De Dominicis E, Finocchi G, Vincenzi M, Calvelli M, Ronconi G, Angelini C, et al. Echocardiographic and pulsed Doppler features in glycogen storage disease type II of the heart (Pompe’s disease). Acta. Cardiol. 1991; 46: 107–114.

    PubMed  Google Scholar 

  35. Metzl JD, Elias ER, Berul CI. An interesting case of infant sudden death: severe hypertrophic cardiomyopathy in Pompe’s disease. Pacing Clin. Electrophysiol. 1999; 22: 821–822.

    Article  PubMed  CAS  Google Scholar 

  36. Mellies U, Ragette R, Schwake C, Baethmann M, Voit T, Teschler H. Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology 2001; 57: 1290–1295.

    Article  PubMed  CAS  Google Scholar 

  37. Servidei S, DiMauro S. Disorders of glycogen metabolism of muscle. Neurol. Clin. 1989; 7: 159–178.

    PubMed  CAS  Google Scholar 

  38. Bodamer OA, Leonard JV, Halliday D. Dietary treatment in late-onset acid maltase deficiency. Eur. J. Pediatr. 1997;156 Suppl 1:S39–S42.

    Google Scholar 

  39. Nicolino MP, Puech JP, Kremer EJ, Reuser AJ, Mbebi C, Verdiere-Sahuque M, et al. Adenovirus-mediated transfer of the acid alpha-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation. Hum. Mol. Genet. 1998; 7: 1695–1702.

    Article  PubMed  CAS  Google Scholar 

  40. Pauly DF, Johns DC, Matelis LA, Lawrence JH, Byrne BJ, Kessler PD. Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle. Gene Ther. 1998; 5: 473–480.

    Article  PubMed  CAS  Google Scholar 

  41. Lehmann-Horn F, Rudel R. Channelopathies: the nondystrophic myotonias and periodic paralyses. Semin. Pediatr. Neurol. 1996; 3: 122–139.

    Article  PubMed  CAS  Google Scholar 

  42. Riggs JE. The periodic paralyses. Neurol. Clin. 1988; 6: 485–498.

    PubMed  CAS  Google Scholar 

  43. Sansone V, Griggs RC, Meola G, Ptacek LJ, Barohn R, Iannaccone S, et al. Andersen’s syndrome: a distinct periodic paralysis. Ann. Neurol. 1997; 42: 305–312.

    Article  PubMed  CAS  Google Scholar 

  44. Hayward L, Brown RH. Periodic paralysis and related mytonic diseases. In: Feldman E (ed). Current Diagnosis in Neurology. St. Louis: Mosby-Year Book, 1993: 353–356.

    Google Scholar 

  45. Gutmann L. Periodic paralyses. Neurol. Clin. 2000; 18: 195–202.

    Article  PubMed  CAS  Google Scholar 

  46. Feero WG, Wang J, Barany F, Zhou J, Todorovic SM, Conwit R, et al. Hyperkalemic periodic paralysis: rapid molecular diagnosis and relationship of genotype to phenotype in 12 families. Neurology 1993; 43: 668–673.

    Article  PubMed  CAS  Google Scholar 

  47. Cannon SC. Sodium channel defects in myotonia and periodic paralysis. Annu. Rev. Neurosci. 1996; 19: 141–164.

    Article  PubMed  CAS  Google Scholar 

  48. Cummins TR, Sigworth FJ. Impaired slow inactivation in mutant sodium channels. Biophys. J. 1996; 71: 227–236.

    Article  PubMed  CAS  Google Scholar 

  49. Fontaine B, Vale-Santos J, Jurkat-Rott K, Reboul J, Plassart E, Rime CS, et al. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31–32 in three European families. Nat. Genet. 1994; 6: 267–272.

    Google Scholar 

  50. Greenberg DA. Calcium channels in neurological disease. Ann. Neurol. 1997; 42: 275–82.

    Article  PubMed  CAS  Google Scholar 

  51. Fardwau M, Tome F. Congenital myopathies. In: Engel A, Franzini-Armstrong C (eds). Myology. New York: McGraw-Hill, 1994: 1516–1519.

    Google Scholar 

  52. Tawil R. Periodic paralysis. In: Johnson R, Griffin J, McArtur J (eds). Current Therapy in Neurologic Disease, 6th ed. St. Louis: Mosby Year Book, 2002: 422–424.

    Google Scholar 

  53. Cherington M. Botulism: clinical and therapeutic observations. Rocky Mt. Med. J. 1972; 69: 55–58.

    PubMed  CAS  Google Scholar 

  54. Wound botulism—California, 1995. MMWR 1995; 44: 889–892.

    Google Scholar 

  55. Kudrow DB, Henry DA, Haake DA, Marshall G, Mathisen GE. Botulism associated with Clostridium botulinum sinusitis after intranasal cocaine abuse. Ann. Intern. Med. 1988; 109: 984–985.

    PubMed  CAS  Google Scholar 

  56. Schantz EJ, Johnson EA. Botulinum toxin: The story of its development for the treatment of human disease. Perspect. Biol. Med. 1997; 40: 317–327.

    PubMed  CAS  Google Scholar 

  57. Burningham MD, Walter FG, Mechem C, Haber J, Ekins BR. Wound botulism. Ann. Emerg. Med. 1994; 24: 1184–1187.

    Article  PubMed  CAS  Google Scholar 

  58. Mandler RN, Maselli RA. Stimulated single-fiber electromyography in wound botulism. Muscle Nerve 1996; 19: 1171–1173.

    Article  PubMed  CAS  Google Scholar 

  59. Pickett J, Berg B, Chaplin E, Brunstetter-Shafer MA. Syndrome of botulism in infancy: Clinical and electrophysiologic study. N. Engl. J. Med. 1976; 295: 770–772.

    Article  PubMed  CAS  Google Scholar 

  60. Cherington M. Botulism. Semin. Neurol. 1990; 10: 27–31.

    Article  PubMed  CAS  Google Scholar 

  61. Goode GB, Shearn DL. Botulism: a case with associated sensory abnormalities. Arch. Neurol. 1982; 39: 55.

    Article  PubMed  CAS  Google Scholar 

  62. Duchen LW, Strich SJ. The effects of botulinum toxin on the pattern of innervation of skeletal muscle in the mouse. Q. J. Exp. Physiol. Cogen. Med. Sci. 1968; 53: 84–89.

    CAS  Google Scholar 

  63. Jenzer G, Mumenthaler M, Ludin HP, Robert F. Autonomic dysfunction in botulism B: A clinical report. Neurology 1975; 25: 150–153.

    Article  PubMed  CAS  Google Scholar 

  64. Girlanda P, Vita G, Nicolosi C, Milone S, Messina C. Botulinum toxin therapy: Distant effects on neuromuscular transmission and autonomic nervous system. J. Neurol. Neurosurg. Psychiatry 1992; 55: 844–845.

    Article  PubMed  CAS  Google Scholar 

  65. Woodruff BA, Griffin PM, McCroskey LM, Smart JF, Wainwright RB, Bryant RG, et al. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975–1988. J. Infect. Dis. 1992; 166: 1281–1286.

    CAS  Google Scholar 

  66. Cherington M. Electrophysiologic methods as an aid in diagnosis of botulism: A review. Muscle Nerve 1982; 5: S28 - S29.

    PubMed  CAS  Google Scholar 

  67. Gutmann L, Bodensteiner J, Gutierrez A. Electrodiagnosis of botulism. J. Pediatr. 1992; 121 (5 Pt 1): 835.

    PubMed  CAS  Google Scholar 

  68. Chaudhry V, Crawford TO. Stimulation single-fiber EMG in infant botulism. Muscle Nerve 1999; 22: 1698–703.

    Article  PubMed  CAS  Google Scholar 

  69. Girlanda P, Dattola R, Messina C. Single fibre EMG in 6 cases of botulism. Acta. Neurol. Scand. 1983; 67: 118–123.

    Article  PubMed  CAS  Google Scholar 

  70. Brown LW. Infant botulism. Adv. Pediatr. 1981; 28: 141–157.

    PubMed  CAS  Google Scholar 

  71. Black RE, Gunn RA. Hypersensitivity reactions associated with botulinal antitoxin. Am. J. Med. 1980; 69: 567–570.

    Article  PubMed  CAS  Google Scholar 

  72. Davis LE, Johnson JK, Bicknell JM, Levy H, McEvoy KM. Human type A botulism and treatment with 3,4- diaminopyridine. Electromyogr. Clin. Neurophysiol. 1992; 32: 379–383.

    PubMed  CAS  Google Scholar 

  73. Oh SJ, Halsey JH, Jr., Briggs DD, Jr. Guanidine in type B botulism. Arch. Intern. Med. 1975; 135: 726–728.

    Article  PubMed  CAS  Google Scholar 

  74. Kappas A. The porphyrias. In: Scriver C (ed). The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1989: 1305–1365.

    Google Scholar 

  75. Sagar S. Toxic and metabolic disorders. In: Samuels M (ed). Manual of Neurologic Therapeutics, 5th ed. Boston: Little, Brown, 1994: 299–301.

    Google Scholar 

  76. Albers JW, Robertson WC Jr, Daube JR. Electrodi agnostic findings in acute porphyric neuropathy. Muscle Nerve 1978; 1: 292–296.

    Article  PubMed  CAS  Google Scholar 

  77. Taylor P. Anticholinesterase agents. In: Gilman A, Goodman L, Rall T, Murad F (eds). The Pharmacological Basis of Therapeutics, 7th ed. New York: Macmillan, 1985: 110–129.

    Google Scholar 

  78. Besser R, Gutmann L, Dillmann U, Weilemann LS, Hopf HC. End-plate dysfunction in acute organophosphate intoxication. Neurology 1989; 39: 561–567.

    Article  PubMed  CAS  Google Scholar 

  79. Wadia RS, Sadagopan C, Amin RB, Sardesai HV. Neurological manifestations of organophosphorous insecticide poisoning. J. Neurol. Neurosurg. Psychiatry 1974; 37: 841–847.

    Article  PubMed  CAS  Google Scholar 

  80. Lotti M, Becker CE, Aminoff MJ. Organophosphate polyneuropathy: pathogenesis and prevention. Neurology 1984; 34: 658–662.

    Article  PubMed  CAS  Google Scholar 

  81. Cherniack MG. Organophosphorus esters and polyneuropathy. Ann. Intern. Med. 1986; 104: 264–266.

    PubMed  CAS  Google Scholar 

  82. Namba T, Nolte CT, Jackrel J, Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am. J. Med. 1971; 50: 475–492.

    Article  PubMed  CAS  Google Scholar 

  83. Gutmann L, Besser R. Organophosphate intoxication: Pharmacologic, neurophysiologic, clinical, and therapeutic considerations. Semin. Neurol. 1990; 10: 46–51.

    Article  PubMed  CAS  Google Scholar 

  84. Bond GR. Snake, spider, and scorpion envenomation in North America. Pediatr. Rev. 1999; 20: 147–150.

    Article  PubMed  CAS  Google Scholar 

  85. Watt G, Padre L, Tuazon L, Theakston RD, Laughlin L. Bites by the Philippine cobra (Naja naja philippinensis): Prominent neurotoxicity with minimal local signs. Am. J. Trop. Med. Hyg. 1988; 39: 306–311.

    PubMed  CAS  Google Scholar 

  86. Minton SA. Neurotoxic snake envenoming. Semin. Neurol. 1990; 10: 52–61.

    Article  PubMed  CAS  Google Scholar 

  87. Watt G, Theakston RD, Hayes CG, Yambao ML, Sangalang R, Ranoa CP, et al. Positive response to edrophonium in patients with neurotoxic envenoming by cobras (Naja naja philippinensis). A placebo-controlled study. N. Engl. J. Med. 1986; 315: 1444–1448.

    Article  PubMed  CAS  Google Scholar 

  88. Patten BR, Pearn JH, DeBuse P, Burke J, Covacevich J. Prolonged intensive therapy after snake bite. A probable case of envenomation by the rough-scaled snake. Med. J. Aust. 1985; 142: 467–469.

    PubMed  CAS  Google Scholar 

  89. Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Clinical presentation and treatment of black widow spider envenomation: a review of 163 cases. Ann. Emerg. Med. 1992; 21: 782–787.

    Article  PubMed  CAS  Google Scholar 

  90. Kincaid JC. Tick bite paralysis. Semin. Neurol. 1990; 10: 32–34.

    Article  PubMed  CAS  Google Scholar 

  91. Njau BC, Nyindo M, Mutani A. Immunological responses and the role of the paralyzing toxin in rabbits infested with Rhipicephalus evertsi evertsi. Am. J. Trop. Med. Hyg. 1986; 35: 1248–1255.

    PubMed  CAS  Google Scholar 

  92. Stone BF, Neish AL, Wright IG. Immunization of rabbits to produce high serum titres of neutralizing antibodies and immunity to the paralyzing toxin of Ixodes holocyclus. Aust. J. Exp. Biol. Med. Sci. 1982;60 Pt 4:351–358.

    Google Scholar 

  93. Andersen RD. Colorado tick fever and tick paralysis in a young child. Pediatr. Infect. Dis. 1983; 2: 43–44.

    Article  PubMed  CAS  Google Scholar 

  94. Pearn J. Neuromuscular paralysis caused by tick envenomation. J. Neurol. Sci. 1977; 34: 37–42.

    Article  PubMed  CAS  Google Scholar 

  95. Donat JR, Donat JF. Tick paralysis with persistent weakness and electromyographic abnormalities. Arch. Neurol. 1981; 38: 59–61.

    Article  PubMed  CAS  Google Scholar 

  96. Swift TR, Ignacio OJ. Tick paralysis: Electrophysiologic studies. Neurology 1975; 25: 1130–1133.

    Article  PubMed  CAS  Google Scholar 

  97. Tibballs J, Cooper SJ. Paralysis with Ixodes cornuatus envenomation. Med. J. Aust. 1986; 145: 37–38.

    PubMed  CAS  Google Scholar 

  98. Bolton CF. Critical illness polyneuropathy and myopahty. Crit. Care Med. 2001; 29: 2388–2390.

    Article  PubMed  CAS  Google Scholar 

  99. de Letter MAC, Schmitz PIM, Visser LH, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit. Care Med. 2001; 29: 2281–2286.

    Article  PubMed  Google Scholar 

  100. Hund EF, Fogel W, Krieger D, DeGeorgia M, Hacke W. Critical illness polyneuropathy: Clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit. Care Med. 1996; 24: 1328–1333.

    Article  PubMed  CAS  Google Scholar 

  101. Latronico N, Fenzi F, Recupero D, et al. Critical illness myopathy and neuropathy. Lancet 1996; 347: 1579–1582.

    Article  PubMed  CAS  Google Scholar 

  102. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit. Care Med. 1996; 24: 1408–1416.

    Article  PubMed  CAS  Google Scholar 

  103. Schwarz J, Planck J, Briegel J, Straube A. Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for alesion of terminal motor axons. Muscle Nerve 1997; 20: 696–701.

    Article  PubMed  CAS  Google Scholar 

  104. Hund E. Myopathy in critically ill patients. Crit. Care Med. 1999; 27: 2544–2547.

    Article  PubMed  CAS  Google Scholar 

  105. Hund E. Critical illness polyneuropathy. Curr. Opin. Neurol. 2001; 14: 649–653.

    Article  PubMed  CAS  Google Scholar 

  106. Hund E. Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J. Neurol. 2001; 248: 929–934.

    Article  PubMed  CAS  Google Scholar 

  107. Mohr M, Englisch L, Roth A, et al. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med. 1997; 23: 1144–1149.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Michel T. Torbey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jose I. Suarez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Romergryko Geocadin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurosciences Critical Care, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH, USA

    Jose I. Suarez MD

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Torbey, M.T., Suarez, J.I., Geocadin, R. (2004). Less Common Causes of Quadriparesis and Respiratory Failure. In: Suarez, J.I. (eds) Critical Care Neurology and Neurosurgery. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-660-7_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-660-7_28

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-350-3

  • Online ISBN: 978-1-59259-660-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation